OCUVIR 800 DT TABLET

Targeted Viral DNA Replication Suppression:
Ocuvir 800 DT targets herpesvirus replication at the cellular level by exploiting the virus's own thymidine kinase enzyme to convert acyclovir into its active antiviral form selectively within infected cells. This precision-targeted activation sharply limits activity in uninfected host tissue, delivering powerful antiviral effect where it is needed most while preserving your companion animal's healthy cells.

Reduced Severity and Duration of Herpetic Outbreaks:
By halting viral DNA chain elongation and blocking further viral spread, Ocuvir 800 DT alleviates the painful, ulcerative, and vesicular lesions associated with herpes simplex and herpes zoster infections, including cold sores, genital sores, and shingles rashes. Consistent, timely administration reduces both the intensity and the duration of active outbreaks, supporting faster healing and meaningful relief from pain, itching, and discomfort.

Prevention of Viral Dissemination and Reactivation:
Ocuvir 800 DT restricts the spread of actively replicating virus through surrounding tissue, lowering the overall viral burden and reducing the risk of disseminated herpetic disease in immunocompromised patients. Long-term suppressive use, where prescribed by a veterinarian, can reduce the frequency of recurrent reactivation episodes in susceptible animals, providing a sustained shield against the cyclical flare pattern characteristic of latent herpesvirus infections.

Dispersible Tablet Format for Flexible Veterinary Administration:
The DT (dispersible tablet) formulation of Ocuvir 800 allows the tablet to be dissolved in water prior to administration, providing significantly greater flexibility in dosing for companion animals compared to standard film-coated tablets. This dispersibility facilitates more accurate dose measurement, easier syringe-based oral administration for resistant patients, and improved palatability, making the treatment course more manageable for both the pet parent and the companion animal.

High-Dose Formulation for Serious Viral Conditions:
At 800mg per tablet, Ocuvir 800 DT delivers a high-concentration dose of acyclovir specifically suited for the management of more severe and acute herpetic conditions, including shingles and primary herpes zoster infections, where higher antiviral loading is required to achieve effective viral suppression. This makes it a clinically appropriate option for serious acute presentations when prescribed within a structured veterinary antiviral treatment plan.

How to Use:

Ocuvir 800 DT Tablet is a prescription medication and must be administered only under the explicit direction and supervision of a qualified veterinarian, who will determine the appropriate dose, frequency, and duration of therapy based on the species, body weight, clinical condition, and immune status of your companion animal. The dispersible tablet should be dissolved in an appropriate quantity of water as directed by your veterinarian before administration, and should never be crushed and given dry or swallowed whole without dissolution, as the dispersible formulation is specifically designed for dissolution prior to use. It may be given with or without food, though administering it at consistent, regular intervals is strongly recommended to maintain effective plasma concentrations across the dosing schedule. Adequate hydration is critically important throughout the course of treatment, as acyclovir is renally excreted and insufficient fluid intake can elevate plasma drug concentrations and increase the risk of renal crystallisation and associated kidney injury. Never double a missed dose; if a dose is missed, administer it as soon as it is recalled unless the next dose is imminent. Do not discontinue the course of treatment early, even if the animal appears to be improving, as premature cessation may allow viral rebound. For any use in cats, strict veterinary authorisation and close monitoring are mandatory given species-specific safety considerations.

Storage Advice:

Store unopened Ocuvir 800 DT Tablet in a cool, dry place below 25 degrees C away from direct sunlight. Do not freeze. Once opened, keep the strip in its original blister packaging and reseal carefully after each use to protect the remaining tablets from moisture and humidity. Once dissolved in water, the solution should be administered immediately and must not be stored for later use. Keep out of reach of children and pets at all times. Do not use after the best-before date printed on the blister strip or carton.

About the Brand:

Founded in 1936 by the late Mr. Anand Chandavarkar as a partnership firm in Mumbai, FDC Limited was formally incorporated as a private limited company in 1940 and has since grown into one of India's top 25 fully integrated pharmaceutical companies, earning accreditations from the US-FDA, UK-MHRA, WHO-GMP, MCC (South Africa), ANVISA (Brazil), and the UAE regulatory authorities across its multi-location manufacturing facilities in Maharashtra, Goa, and Himachal Pradesh. FDC is a recognised pioneer in Oral Rehydration Solutions and ophthalmic therapies in India, and has a particularly distinguished history in antiviral pharmaceutical development, including the proprietary development of Ocuvir SR, an extended-release acyclovir formulation for herpes zoster in immunocompetent patients that earned FDC the PHARMEXCIL Certificate of Appreciation Patent Award. FDC's enduring philosophy of delivering accessible, high-quality, innovation-driven healthcare solutions to patients across the globe, backed by in-house R&D centres recognised by India's Department of Science and Technology, aligns with Animeal's commitment to offering trusted, clinically validated pharmaceutical solutions for your companion animal's health and wellbeing. Discover FDC Limited today.

Disclaimer:

Please note that while Ocuvir 800 DT Tablet is formulated from acyclovir 800mg and is appropriate for veterinary use in select species and presentations, it is a prescription-only pharmaceutical and must not be administered to any companion animal without prior veterinary examination, diagnosis, and a written prescription. It is a complementary antiviral therapeutic agent and is not a substitute for comprehensive diagnostic workup, immune status assessment, or ongoing clinical monitoring by a qualified veterinarian. Systemic oral acyclovir is contraindicated in cats due to the risk of bone marrow suppression and its low bioavailability in this species; only a veterinarian can determine if any form of acyclovir is appropriate for a feline patient. For companion animals with pre-existing kidney disease, dehydration, compromised immune function, or concurrent use of nephrotoxic medications such as tenofovir or cidofovir, consult your veterinarian before introducing this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.